HCV NS3 recombinant antigens and mutants thereof for improved antibody detection
US9790478B2 · kind B2 · utility
2Cited by
115References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 2013 |
| Grant date | Oct 17, 2017 |
| Priority date | — |
| Expiry date | Dec 23, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2469/20
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure relates to polypeptides, including fusions thereof, nucleic acids, vectors, host cells, immunodiagnostic reagents, kits, and immunoassays for use detecting the presence of HCV antibodies. More specifically, the present invention describes specific NS3 antigens that can be used for the detection of anti-HCV antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.